Canada markets open in 7 hours 19 minutes

Corvus Pharmaceuticals, Inc. (C17.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.5620+0.1200 (+8.32%)
As of 08:05AM CEST. Market open.
Currency in EUR
Earnings EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts3323
Avg. Estimate-0.26-0.22-1.07-0.9
Low Estimate-0.35-0.29-1.23-0.95
High Estimate-0.18-0.14-0.91-0.79
Year Ago EPS-0.330.92-0.2-1.07
Revenue EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts3333
Avg. EstimateN/AN/AN/A45.5M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A136.5M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2020-09-302020-12-312021-03-312021-06-30
EPS Est.-0.24-0.32-0.31-0.32
EPS Actual-0.330.92-0.34-0.28
Difference-0.091.24-0.030.04
Surprise %-37.50%387.50%-9.70%12.50%
EPS TrendCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.26-0.22-1.07-0.9
7 Days Ago-0.26-0.22-1.07-0.9
30 Days Ago-0.26-0.22-1.07-0.9
60 Days Ago-0.32-0.29-1.24-0.93
90 Days Ago-0.38-0.39-1.42-1.16
EPS RevisionsCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesC17.FIndustrySector(s)S&P 500
Current Qtr.21.20%N/AN/AN/A
Next Qtr.-123.90%N/AN/AN/A
Current Year-435.00%N/AN/AN/A
Next Year15.90%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A